Univest
Univest
  • Markets
  • ABSL Dynamic Bond Direct IDCW: NAV Today, Performance Review and Should You Invest?

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    ABSL Dynamic Bond Direct IDCW

    ABSL Dynamic Bond Direct IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Bansal Wire Share Price Falls 2.22% to Rs 308 After Q1 Results

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Bansal Wire Share Price Falls

    Bansal Wire share price fell 2.22% to Rs 308 as of 23 July 2026, after the company announced its Q1 FY27 results on 22 July 2026. Q1 FY27 PAT stood at Rs 20 crore.

    read more
  • ABSL Dynamic Bond Regular IDCW: NAV Today, Performance Review and Should You Invest?

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    ABSL Dynamic Bond Regular IDCW

    ABSL Dynamic Bond Regular IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • ABSL Dynamic Bond Regular Growth: NAV Today, Performance Review and Should You Invest?

    • July 23, 2026
    • Posted by: Neeraj Pandey
    • Category: Mutual Funds
    No Comments
    ABSL Dynamic Bond Regular Growth

    ABSL Dynamic Bond Regular Growth NAV, latest returns and full review including risks and how to invest.

    read more
  • IIFL Finance Share Price Falls 0.62% to Rs 567.4 After Q1 Results

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    IIFL Finance Share Price Falls

    IIFL Finance share price fell 0.62% to Rs 567.4 as of 23 July 2026, after the company announced its Q1 FY27 results on 22 July 2026. Q1 FY27 PAT stood at Rs 713 crore.

    read more
  • Glenmark Pharmaceuticals vs Torrent Pharmaceuticals Business Model: Which Domestic Branded Formulations Wins

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Glenmark Pharmaceuticals vs Torrent Pharmaceuticals Business Model

    Glenmark Pharmaceuticals vs Torrent Pharmaceuticals business model compares concentrated dermatology and respiratory therapeutic focus with export presence against concentrated cardiac and CNS therapeutic branded formulations leadership to see which domestic branded formulations has better business model.

    read more
  • Indoco Remedies vs Windlas Biotech Business Model: Which Branded and Contract Formulations Wins

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Indoco Remedies vs Windlas Biotech Business Model:

    Indoco Remedies vs Windlas Biotech business model compares domestic branded formulations combined with contract manufacturing exports against concentrated domestic contract manufacturing for branded generics to see which branded and contract formulations has better business model.

    read more
  • ABSL Govenment Securities Regular Quarterly IDCW: NAV Today, Performance Review and Should You Invest?

    • July 23, 2026
    • Posted by: Neeraj Pandey
    • Category: Mutual Funds
    No Comments
    ABSL Govenment Securities Regular Quarterly IDCW

    ABSL Govenment Securities Regular Quarterly IDCW NAV, latest returns and full review including risks and how to invest.

    read more
  • Pfizer India vs Mankind Pharma Business Model: Which Pharmaceuticals Wins

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Pfizer India vs Mankind Pharma Business

    Pfizer India vs Mankind Pharma business model compares innovator drug portfolio leveraging global parent research pipeline against scale-led domestic branded generics combined with consumer healthcare products to see which pharmaceuticals has better business model.

    read more
  • Ipca Laboratories vs Alkem Laboratories Business Model: Which Domestic Branded Formulations Wins

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Ipca Laboratories vs Alkem Laboratories Business Model:

    Ipca Laboratories vs Alkem Laboratories business model compares concentrated anti-malarial and pain management therapeutic specialisation against concentrated anti-infective and pain management branded formulations to see which domestic branded formulations has better business model.

    read more
  • 1
  • …
  • 1,273
  • 1,274
  • 1,275
  • 1,276
  • 1,277
  • …
  • 2,705